Now Approved – COSENTYX® (secukinumab): New Expanded Indication in Pediatric PsO, Presented by Novartis.

August 26, 2021

Join Lawrence Eichenfield, MD, Chief of Pediatric and Adolescent Dermatology at Rady Children’s Hospital-San Diego, as he discusses the expanded indication of this product. Dr. Eichenfield also serves as the Vice-Chair of the Department of Dermatology at the UC San Diego School of Medicine, and Professor of Dermatology and Pediatrics; and he is board certified in Dermatology, Pediatric Dermatology and Pediatrics.